Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.125
+0.135 (6.78%)
At close: Mar 13, 2026, 4:00 PM EDT
2.130
+0.005 (0.24%)
After-hours: Mar 13, 2026, 4:10 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $82.01 million as of March 13, 2026. Its market cap has decreased by -42.84% in one year.
Market Cap
82.01M
Enterprise Value
-17.73M
1-Year Change
-42.84%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $82.01M, a decrease of -83.20%. That is a compound annual growth rate of -31.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 82.21M | -27.80% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Picard Medical | 95.81M |
| Treace Medical Concepts | 91.48M |
| MaxCyte | 90.64M |
| Xtant Medical Holdings | 89.74M |
| Baird Medical Investment Holdings | 89.43M |
| Neuronetics | 88.69M |
| Pulmonx | 73.92M |
| QT Imaging Holdings | 72.74M |